Seema Gadhia

Apr 16, 2024 | pharmaceutical-journal.com | Seema Gadhia |Helena Sakota |Hitasha Rupani |James Rose

Asthma is a disease characterised by chronic airway inflammation and hyper-responsiveness that can vary over time and in intensity. There are many respiratory symptoms — such as wheeze, shortness of breath, chest tightness and cough — and people may also exhibit variable expiratory airflow limitation​[1]​. Owing to its heterogenous nature, asthma management requires regular reviews and interventions appropriately tailored to the patient’s current level of severity​[2]​.